Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial - Miras, A D; Perez-Pevida, B; Aldhwayan, M (Lancet Diabetes Endocrinol, 2019)